Who owns Enochian Biosciences Inc?
- Ticker: RENB
- CUSIP Number: 29350e104
Tip: Access positions for across all investors
Analyze quarterly positions in Enochian Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Enochian Biosciences stock
Who bought or sold Enochian Biosciences Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 390k | $1.2M | 44% | Dec 2023 |
|
Millennium Management | 126k | $400k | -34% | Dec 2023 |
|
683 Capital Management | 74k | $234k | 100% | Dec 2023 |
|
Laurion Capital Management | 62k | $195k | 100% | Dec 2023 |
|
Jane Street | 57k | $180k | 100% | Dec 2023 |
|
Citigroup | 51k | $170k | 177% | Dec 2023 |
|
Bank of America Corporation | 46k | $147k | 2499% | Dec 2023 |
|
Citadel Advisors | 37k | $118k | 29% | Dec 2023 |
|
Dimensional Fund Advisors | 36k | $115k | 70% | Dec 2023 |
|
Jpmorgan Chase & Co | 30k | $95k | 100% | Dec 2023 |
|
Balyasny Asset Management | 26k | $82k | 100% | Dec 2023 |
|
MSA Advisors | 25k | $79k | 100% | Dec 2023 |
|
Virtu Financial | 19k | $59k | 100% | Dec 2023 |
|
William Blair $ Company | 16k | $51k | -38% | Dec 2023 |
|
Hsbc Holdings | 15k | $49k | 100% | Dec 2023 |
|
Hrt Financial | 14k | $45k | 100% | Dec 2023 |
|
Schonfeld Strategic Advisors | 13k | $43k | 100% | Dec 2023 |
|
Goldman Sachs Group | 13k | $41k | 100% | Dec 2023 |
|
UBS Group | 8.1k | $26k | 35% | Dec 2023 |
|
Lazard Asset Management | 3.9k | $0 | 100% | Dec 2023 |
|
Bnp Paribas Arbitrage, Snc | 1.2k | $3.8k | -65% | Dec 2023 |
|
Wells Fargo & Company | 287.00 | $909.990900 | 34% | Dec 2023 |
|
Who sold out of Enochian Biosciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Cubist Systematic Strategies | Sep 2023 | 11k | $49k |
Bank of New York Mellon | Dec 2023 | 11k | $34k |
Simplex Trading | Dec 2023 | 96.00 | $0 |